Back to Search
Start Over
Interferon-alpha or homoharringtonine as salvage treatment for chronic myeloid leukemia patients who acquire the T315I BCR-ABL mutation.
- Source :
-
Blood [Blood] 2007 Oct 01; Vol. 110 (7), pp. 2779-80. - Publication Year :
- 2007
- Subjects :
- Aged
Fusion Proteins, bcr-abl metabolism
Homoharringtonine
Humans
Isoleucine genetics
Isoleucine metabolism
Kinetics
Male
Tyrosine genetics
Tyrosine metabolism
Fusion Proteins, bcr-abl genetics
Harringtonines therapeutic use
Interferon-alpha therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive genetics
Mutation genetics
Salvage Therapy
Subjects
Details
- Language :
- English
- ISSN :
- 0006-4971
- Volume :
- 110
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Blood
- Publication Type :
- Report
- Accession number :
- 17881650
- Full Text :
- https://doi.org/10.1182/blood-2007-06-094508